ChromaDex (NASDAQ: CDXC) reported Q3 EPS of ($0.07), $0.02 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $5.01 million.

For earnings history and earnings-related data on ChromaDex (CDXC) click here.